Scientists linked two cellular aging processes—senescence and ferroptosis—through acid ceramidase, a targetable enzyme that makes old cells die faster. Vulnerable senescent cells can spread their weakness to neighboring cells, but removing acid ceramidase protected both young and old cells from ferroptosis.
News-Medical
· Jul 24, 2026
· health
· 4 min de leitura
High
Apuração: Verificado
Salk scientists identify acid ceramidase as key target for extending healthspan
◉
Science & Space
8166 artigos relacionados
NASA Launches Artemis II: Four Astronauts Head to Moon in Historic Mis…
Devdiscourse · 100% correspondência
Artemis II astronauts break Earth's orbit, beginning historic three-da…
The Guardian · 99% correspondência
Artemis crew fires engines toward Moon in historic lunar flyby mission
RTE.ie · 99% correspondência
Astronauts will be 'living and working on the moon' within a decade, s…
Sky News · 99% correspondência
Artemis II re-entry: Hansen, crew ‘focusing on getting it all done rig…
Global News · 99% correspondência
Cobertura Relacionada
The New York Times · Sep 19
Smithsonian Uses DNA From Jefferson's Hair to Confirm Hemings Children
The Smithsonian Institution has used advanced genomics on Thomas Jefferson's hair to provide definitive proof he fathere…
Mashable · Sep 19 Moon in Waxing Gibbous phase on Sept. 19; Full Moon arrives Sept. 26The Moon enters its Waxing Gibbous phase on September 19, 2026, with 54% illumination visible before reaching Full Moon …
EurekAlert! · Sep 19 Tokyo researchers optimize ultra-thin wings for Mars drones using bio-inspired designTokyo Metropolitan University researchers used evolutionary algorithms to design ultra-thin, corrugated airfoils optimiz…
ScienceDaily · Sep 19 First Diplodocus fossil found outside North America discovered in SpainSpanish paleontologists identified a 150-million-year-old Diplodocus fossil from the Late Jurassic period, the first con…
Viés e Enquadramento
⚖
Science-focused article presenting research findings with optimistic framing about therapeutic potential, minimal apparent bias in reporting factual discovery.
Bias Direction
center
Confidence
MED
Progress narrative: frames aging research as a solution-oriented scientific breakthrough with practical therapeutic applications already in development. Emphasizes hope and innovation potential.
lighting the way to future innovation
big milestone in the ongoing public health effort
could extend healthspans
novel target for developing new therapeutics
Skeptical or cautionary scientific voices questioning the findings or timeline to clinical application
Cost and accessibility considerations for potential treatments
Ethical implications of life extension technologies
Competing research approaches or alternative theories in aging research
Patient or public health expert perspectives on healthspan vs. lifespan priorities
Impacto Geopolítico
🌎
Biomedical research breakthrough on aging has no direct geopolitical implications; focuses on cellular mechanisms for healthspan extension.
Escalation Risk
low
Confidence
HIGH
No immediate power dynamics shifts. Long-term: nations investing in longevity research may gain economic/demographic advantages.
Lente Econômica
📈
Salk Institute discovery of acid ceramidase as aging target could enable therapeutic interventions to extend healthspan, potentially creating new pharmaceutical market opportunities in age-related disease treatment.
Market Signal
bullish
Confidence
MED
Pharmaceutical and Biotechnology
Healthcare and Medical Devices
Gerontology and Aging Services
Long-term Care and Senior Living
Health Insurance
Aging populations could benefit from extended healthspan and delayed onset of age-related diseases (arthritis, Alzheimer's, Parkinson's), potentially reducing healthcare costs and improving quality of life for seniors and their families.
Regulatory agencies (FDA) may accelerate approval pathways for acid ceramidase-targeting therapeutics; healthcare systems may need to adjust reimbursement models; public health initiatives could prioritize aging research funding; insurance coverage policies may evolve around preventive gerontological treatments.